Publications & Presentations

Publications & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:
STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD®) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients

Timothy R. Smith MD; Paul Winner DO; Sheena K. Aurora MD; Maria Jeleva PhD; Jasna Hocevar- Trnka MD; Stephen B. Shrewsbury MB ChB Full manuscript can be accessed here: https://headachejournal.onlinelibrary.wiley.com/doi/epdf/10.1111/head.14184 Objective: To report the safety, tolerability, exploratory efficacy, and patient…

READ MORE

A link between gastrointestinal disorders and migraine: Insights into the gut–brain connection

Sheena K. Aurora MD; Stephen B. Shrewsbury MB, ChB; Sutapa Ray PhD; Nada Hindiyeh MD; and Linda Nguyen MD Full manuscript can be accessed here: https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14099 Background: Migraine is a complex, multifaceted, and disabling headache disease that is often complicated by…

READ MORE

Drug delivery via the upper nasal space: A novel route for anesthesiologists, intensivists and emergency department physicians?

Stephen Shrewsbury, Jasna Hocevar-Trnka, and John Hoekman Full manuscript can be accessed here: https://probiologists.com/Uploads/Articles/10_637521815510349420.pdf Many drugs are effective systemically, but slow onset of non-intravenous routes of administration may limit their clinical utility. While anesthesiologists usually have intravenous (IV) access for…

READ MORE